Melatonin level as a risk factor for age-related macular degeneration
Background. The current trend towards an increase in age-related macular degeneration (AMD) incidence rate in the population, including the working-age population, with a possible loss of professional activity, indicates the need for early preclinical identification of risk groups, timely prevention...
Guardado en:
Autores principales: | N. S. Khodzhaev, A. D. Chuprov, S. M. Kim, O. V. Marshinskaya, T. V. Kazakova |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
Scientific Сentre for Family Health and Human Reproduction Problems
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3dd50415a6e047fdbafd70db4dce5a67 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
CYTOKINES IN LACRIMAL FLUID AND BLOOD SERUM: EARLY BIOMARKERS OF AGE-RELATED MACULAR DEGENERATION
por: O. S. Slepova, et al.
Publicado: (2015) -
Prevalence of and risk factors for age-related macular degeneration in Nepal: the Bhaktapur Retina Study
por: Thapa R, et al.
Publicado: (2017) -
Management of neovascular age-related macular degeneration: Taiwan expert consensus
por: Ling Yeung, et al.
Publicado: (2021) -
Recent developments in age-related macular degeneration: a review
por: Al-Zamil WM, et al.
Publicado: (2017) -
PERIPHERAL BLOOD SUBPOPULATION OF LYMPHOCYTES OF PATIENTS WITH AGE-RELATED MACULAR DEGENERATION
por: N. V. Balatskaya, et al.
Publicado: (2015)